Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2020-11, Vol.136 (19), p.2229-2232
Hauptverfasser: Lurain, Kathryn, Uldrick, Thomas S., Ramaswami, Ramya, Polizzotto, Mark N., Goncalves, Priscila H., Widell, Anaida, Steinberg, Seth M., Jaffe, Elaine S., Pittaluga, Stefania, Wang, Hao-Wei, Yuan, Constance M., Tamula, Mary Anne, Martin, Staci, Wolters, Pamela L., George, Jomy, Little, Richard F., Yarchoan, Robert
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2232
container_issue 19
container_start_page 2229
container_title Blood
container_volume 136
creator Lurain, Kathryn
Uldrick, Thomas S.
Ramaswami, Ramya
Polizzotto, Mark N.
Goncalves, Priscila H.
Widell, Anaida
Steinberg, Seth M.
Jaffe, Elaine S.
Pittaluga, Stefania
Wang, Hao-Wei
Yuan, Constance M.
Tamula, Mary Anne
Martin, Staci
Wolters, Pamela L.
George, Jomy
Little, Richard F.
Yarchoan, Robert
description
doi_str_mv 10.1182/blood.2020006048
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7645985</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497121004997</els_id><sourcerecordid>2419714161</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-7f9ca3caf4ffb8c4c6d3f87c90410e683775c1f268fe3ad67e31775ca72c28013</originalsourceid><addsrcrecordid>eNp1UcFuEzEUtCpQmxbunJCPHLrF9nrX3h6QqojSShU9tHC1HPu562p3HWwnbf4eh4QCB06WxjPz3ptB6B0lZ5RK9nExhGDPGGGEkJZweYBmtGGyIgV5hWZbtOKdoEfoOKVHQiivWXOIjmrWkk5SPkPpPoLOI0wZB4evrr9XOqVgvM5g8TL6UccNnn-9w8NmXPZh1PjJ5x7rKfsIOYa1j3rAuYeol5tTHH1ePRfR4rRQLO79Q1_ZkACPkPuQIzwX4zfotdNDgrf79wR9u_x8P7-qbm6_XM8vbirDuciVcJ3RtdGOO7eQhpvW1k4K0xFOCbSyFqIx1LFWOqi1bQXUdAtpwQyThNYn6NPOd7lajGBNObIsq_ZXqaC9-vdn8r16CGslWt50sikGH_YGMfxYQcpq9MnAMOgJwiopxmkJl9N2O4vsqCaGlCK4lzGUqG1X6ldX6k9XRfL-7_VeBL_LKYTzHQFKSGsPUSXjYTJgS_YmKxv8_91_Au5Up1Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2419714161</pqid></control><display><type>article</type><title>Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Lurain, Kathryn ; Uldrick, Thomas S. ; Ramaswami, Ramya ; Polizzotto, Mark N. ; Goncalves, Priscila H. ; Widell, Anaida ; Steinberg, Seth M. ; Jaffe, Elaine S. ; Pittaluga, Stefania ; Wang, Hao-Wei ; Yuan, Constance M. ; Tamula, Mary Anne ; Martin, Staci ; Wolters, Pamela L. ; George, Jomy ; Little, Richard F. ; Yarchoan, Robert</creator><creatorcontrib>Lurain, Kathryn ; Uldrick, Thomas S. ; Ramaswami, Ramya ; Polizzotto, Mark N. ; Goncalves, Priscila H. ; Widell, Anaida ; Steinberg, Seth M. ; Jaffe, Elaine S. ; Pittaluga, Stefania ; Wang, Hao-Wei ; Yuan, Constance M. ; Tamula, Mary Anne ; Martin, Staci ; Wolters, Pamela L. ; George, Jomy ; Little, Richard F. ; Yarchoan, Robert</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>ISSN: 1528-0020</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood.2020006048</identifier><identifier>PMID: 32609814</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Antiretroviral Therapy, Highly Active - methods ; Central Nervous System Neoplasms - drug therapy ; Central Nervous System Neoplasms - pathology ; Central Nervous System Neoplasms - virology ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; HIV - isolation &amp; purification ; HIV Infections - complications ; HIV Infections - drug therapy ; HIV Infections - virology ; Humans ; Letter to ; Lymphoma, Non-Hodgkin - drug therapy ; Lymphoma, Non-Hodgkin - pathology ; Lymphoma, Non-Hodgkin - virology ; Male ; Methotrexate - administration &amp; dosage ; Middle Aged ; Prognosis ; Prospective Studies ; Rituximab - administration &amp; dosage ; Survival Rate</subject><ispartof>Blood, 2020-11, Vol.136 (19), p.2229-2232</ispartof><rights>2020 American Society of Hematology</rights><rights>2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-7f9ca3caf4ffb8c4c6d3f87c90410e683775c1f268fe3ad67e31775ca72c28013</citedby><cites>FETCH-LOGICAL-c447t-7f9ca3caf4ffb8c4c6d3f87c90410e683775c1f268fe3ad67e31775ca72c28013</cites><orcidid>0000-0002-2601-3665 ; 0000-0001-7688-1439 ; 0000-0002-5794-7292 ; 0000-0002-3057-1395 ; 0000-0003-4632-0301</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32609814$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lurain, Kathryn</creatorcontrib><creatorcontrib>Uldrick, Thomas S.</creatorcontrib><creatorcontrib>Ramaswami, Ramya</creatorcontrib><creatorcontrib>Polizzotto, Mark N.</creatorcontrib><creatorcontrib>Goncalves, Priscila H.</creatorcontrib><creatorcontrib>Widell, Anaida</creatorcontrib><creatorcontrib>Steinberg, Seth M.</creatorcontrib><creatorcontrib>Jaffe, Elaine S.</creatorcontrib><creatorcontrib>Pittaluga, Stefania</creatorcontrib><creatorcontrib>Wang, Hao-Wei</creatorcontrib><creatorcontrib>Yuan, Constance M.</creatorcontrib><creatorcontrib>Tamula, Mary Anne</creatorcontrib><creatorcontrib>Martin, Staci</creatorcontrib><creatorcontrib>Wolters, Pamela L.</creatorcontrib><creatorcontrib>George, Jomy</creatorcontrib><creatorcontrib>Little, Richard F.</creatorcontrib><creatorcontrib>Yarchoan, Robert</creatorcontrib><title>Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate</title><title>Blood</title><addtitle>Blood</addtitle><subject>Adult</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Antiretroviral Therapy, Highly Active - methods</subject><subject>Central Nervous System Neoplasms - drug therapy</subject><subject>Central Nervous System Neoplasms - pathology</subject><subject>Central Nervous System Neoplasms - virology</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>HIV - isolation &amp; purification</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - virology</subject><subject>Humans</subject><subject>Letter to</subject><subject>Lymphoma, Non-Hodgkin - drug therapy</subject><subject>Lymphoma, Non-Hodgkin - pathology</subject><subject>Lymphoma, Non-Hodgkin - virology</subject><subject>Male</subject><subject>Methotrexate - administration &amp; dosage</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Rituximab - administration &amp; dosage</subject><subject>Survival Rate</subject><issn>0006-4971</issn><issn>1528-0020</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UcFuEzEUtCpQmxbunJCPHLrF9nrX3h6QqojSShU9tHC1HPu562p3HWwnbf4eh4QCB06WxjPz3ptB6B0lZ5RK9nExhGDPGGGEkJZweYBmtGGyIgV5hWZbtOKdoEfoOKVHQiivWXOIjmrWkk5SPkPpPoLOI0wZB4evrr9XOqVgvM5g8TL6UccNnn-9w8NmXPZh1PjJ5x7rKfsIOYa1j3rAuYeol5tTHH1ePRfR4rRQLO79Q1_ZkACPkPuQIzwX4zfotdNDgrf79wR9u_x8P7-qbm6_XM8vbirDuciVcJ3RtdGOO7eQhpvW1k4K0xFOCbSyFqIx1LFWOqi1bQXUdAtpwQyThNYn6NPOd7lajGBNObIsq_ZXqaC9-vdn8r16CGslWt50sikGH_YGMfxYQcpq9MnAMOgJwiopxmkJl9N2O4vsqCaGlCK4lzGUqG1X6ldX6k9XRfL-7_VeBL_LKYTzHQFKSGsPUSXjYTJgS_YmKxv8_91_Au5Up1Y</recordid><startdate>20201105</startdate><enddate>20201105</enddate><creator>Lurain, Kathryn</creator><creator>Uldrick, Thomas S.</creator><creator>Ramaswami, Ramya</creator><creator>Polizzotto, Mark N.</creator><creator>Goncalves, Priscila H.</creator><creator>Widell, Anaida</creator><creator>Steinberg, Seth M.</creator><creator>Jaffe, Elaine S.</creator><creator>Pittaluga, Stefania</creator><creator>Wang, Hao-Wei</creator><creator>Yuan, Constance M.</creator><creator>Tamula, Mary Anne</creator><creator>Martin, Staci</creator><creator>Wolters, Pamela L.</creator><creator>George, Jomy</creator><creator>Little, Richard F.</creator><creator>Yarchoan, Robert</creator><general>Elsevier Inc</general><general>American Society of Hematology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2601-3665</orcidid><orcidid>https://orcid.org/0000-0001-7688-1439</orcidid><orcidid>https://orcid.org/0000-0002-5794-7292</orcidid><orcidid>https://orcid.org/0000-0002-3057-1395</orcidid><orcidid>https://orcid.org/0000-0003-4632-0301</orcidid></search><sort><creationdate>20201105</creationdate><title>Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate</title><author>Lurain, Kathryn ; Uldrick, Thomas S. ; Ramaswami, Ramya ; Polizzotto, Mark N. ; Goncalves, Priscila H. ; Widell, Anaida ; Steinberg, Seth M. ; Jaffe, Elaine S. ; Pittaluga, Stefania ; Wang, Hao-Wei ; Yuan, Constance M. ; Tamula, Mary Anne ; Martin, Staci ; Wolters, Pamela L. ; George, Jomy ; Little, Richard F. ; Yarchoan, Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-7f9ca3caf4ffb8c4c6d3f87c90410e683775c1f268fe3ad67e31775ca72c28013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Antiretroviral Therapy, Highly Active - methods</topic><topic>Central Nervous System Neoplasms - drug therapy</topic><topic>Central Nervous System Neoplasms - pathology</topic><topic>Central Nervous System Neoplasms - virology</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>HIV - isolation &amp; purification</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - virology</topic><topic>Humans</topic><topic>Letter to</topic><topic>Lymphoma, Non-Hodgkin - drug therapy</topic><topic>Lymphoma, Non-Hodgkin - pathology</topic><topic>Lymphoma, Non-Hodgkin - virology</topic><topic>Male</topic><topic>Methotrexate - administration &amp; dosage</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Rituximab - administration &amp; dosage</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lurain, Kathryn</creatorcontrib><creatorcontrib>Uldrick, Thomas S.</creatorcontrib><creatorcontrib>Ramaswami, Ramya</creatorcontrib><creatorcontrib>Polizzotto, Mark N.</creatorcontrib><creatorcontrib>Goncalves, Priscila H.</creatorcontrib><creatorcontrib>Widell, Anaida</creatorcontrib><creatorcontrib>Steinberg, Seth M.</creatorcontrib><creatorcontrib>Jaffe, Elaine S.</creatorcontrib><creatorcontrib>Pittaluga, Stefania</creatorcontrib><creatorcontrib>Wang, Hao-Wei</creatorcontrib><creatorcontrib>Yuan, Constance M.</creatorcontrib><creatorcontrib>Tamula, Mary Anne</creatorcontrib><creatorcontrib>Martin, Staci</creatorcontrib><creatorcontrib>Wolters, Pamela L.</creatorcontrib><creatorcontrib>George, Jomy</creatorcontrib><creatorcontrib>Little, Richard F.</creatorcontrib><creatorcontrib>Yarchoan, Robert</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lurain, Kathryn</au><au>Uldrick, Thomas S.</au><au>Ramaswami, Ramya</au><au>Polizzotto, Mark N.</au><au>Goncalves, Priscila H.</au><au>Widell, Anaida</au><au>Steinberg, Seth M.</au><au>Jaffe, Elaine S.</au><au>Pittaluga, Stefania</au><au>Wang, Hao-Wei</au><au>Yuan, Constance M.</au><au>Tamula, Mary Anne</au><au>Martin, Staci</au><au>Wolters, Pamela L.</au><au>George, Jomy</au><au>Little, Richard F.</au><au>Yarchoan, Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2020-11-05</date><risdate>2020</risdate><volume>136</volume><issue>19</issue><spage>2229</spage><epage>2232</epage><pages>2229-2232</pages><issn>0006-4971</issn><issn>1528-0020</issn><eissn>1528-0020</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32609814</pmid><doi>10.1182/blood.2020006048</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-2601-3665</orcidid><orcidid>https://orcid.org/0000-0001-7688-1439</orcidid><orcidid>https://orcid.org/0000-0002-5794-7292</orcidid><orcidid>https://orcid.org/0000-0002-3057-1395</orcidid><orcidid>https://orcid.org/0000-0003-4632-0301</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2020-11, Vol.136 (19), p.2229-2232
issn 0006-4971
1528-0020
1528-0020
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7645985
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adult
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Antiretroviral Therapy, Highly Active - methods
Central Nervous System Neoplasms - drug therapy
Central Nervous System Neoplasms - pathology
Central Nervous System Neoplasms - virology
Drug Therapy, Combination
Female
Follow-Up Studies
HIV - isolation & purification
HIV Infections - complications
HIV Infections - drug therapy
HIV Infections - virology
Humans
Letter to
Lymphoma, Non-Hodgkin - drug therapy
Lymphoma, Non-Hodgkin - pathology
Lymphoma, Non-Hodgkin - virology
Male
Methotrexate - administration & dosage
Middle Aged
Prognosis
Prospective Studies
Rituximab - administration & dosage
Survival Rate
title Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T02%3A37%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20HIV-associated%20primary%20CNS%20lymphoma%20with%20antiretroviral%20therapy,%20rituximab,%20and%20high-dose%20methotrexate&rft.jtitle=Blood&rft.au=Lurain,%20Kathryn&rft.date=2020-11-05&rft.volume=136&rft.issue=19&rft.spage=2229&rft.epage=2232&rft.pages=2229-2232&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood.2020006048&rft_dat=%3Cproquest_pubme%3E2419714161%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2419714161&rft_id=info:pmid/32609814&rft_els_id=S0006497121004997&rfr_iscdi=true